Not Medicare Enrolled

Dr. Jay Lugthart, M.D.

Dermatology · Jenison, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
670 BALDWIN ST, Jenison, MI 49428
6164574610
In practice since 2007 (19 years)
NPI: 1215059241 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lugthart from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lugthart? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lugthart

Dr. Jay Lugthart is a dermatology specialist in Jenison, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lugthart performed 17 Medicare services across 14 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lugthart received a total of $9,645 from 37 pharmaceutical and/or device companies across 433 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lugthart is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 17 Medicare services $9,645 industry payments

Medicare Practice Summary

Medicare Utilization ↗
17
Medicare services
Bottom 1% in MI for dermatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
14
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
17 $82 $168
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2023 ↗
$9,645
Total received (2018-2023)
Avg $1,608/year across 6 years
Top 3% in MI for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
433
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,645 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$937
2022
$1,729
2021
$1,358
2020
$700
2019
$2,298
2018
$2,623

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$447
Novo Nordisk Inc
$178
Amgen Inc.
$69
GlaxoSmithKline, LLC.
$57
Lilly USA, LLC
$36
Teva Pharmaceuticals USA, Inc.
$29
Bayer Healthcare Pharmaceuticals Inc.
$29
Exact Sciences Corporation
$26
Xeris Pharmaceuticals, Inc.
$21
ABBVIE INC.
$17
Supernus Pharmaceuticals, Inc.
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
Top 3 companies account for 74.1% of 2023 payments
All-time payments by company (2018-2023) ›
AstraZeneca Pharmaceuticals LP
$2,967
Novo Nordisk Inc
$1,708
Lilly USA, LLC
$876
GlaxoSmithKline, LLC.
$579
Amgen Inc.
$568
Janssen Pharmaceuticals, Inc
$473
Boehringer Ingelheim Pharmaceuticals, Inc.
$356
ABBVIE INC.
$337
Amarin Pharma Inc.
$249
Novartis Pharmaceuticals Corporation
$236
Merck Sharp & Dohme Corporation
$130
Teva Pharmaceuticals USA, Inc.
$129
Kowa Pharmaceuticals America, Inc.
$125
Bayer HealthCare Pharmaceuticals Inc.
$93
SANOFI-AVENTIS U.S. LLC
$91
Biohaven Pharmaceuticals, Inc.
$84
Astellas Pharma US Inc
$79
Shire North American Group Inc
$51
Paratek Pharmaceuticals, Inc.
$44
Takeda Pharmaceuticals U.S.A., Inc.
$43
Supernus Pharmaceuticals, Inc.
$42
E.R. Squibb & Sons, L.L.C.
$40
AbbVie Inc.
$40
Eisai Inc.
$38
Nabriva Therapeutics, plc
$32
Bayer Healthcare Pharmaceuticals Inc.
$29
Exact Sciences Corporation
$26
Vanda Pharmaceuticals Inc.
$26
Promius Pharma LLC
$25
PFIZER INC.
$23
Xeris Pharmaceuticals, Inc.
$21
Biohaven Pharmaceutical Holding Company Ltd.
$17
Merck Sharp & Dohme LLC
$15
Allergan, Inc.
$15
Sanofi Pasteur Inc.
$14
Esperion Therapeutics, Inc.
$13
Antares Pharma, Inc.
$12
Top 3 companies account for 57.6% of all-time payments
Associated products mentioned in payments ›
AJOVY · ANORO · ANORO ELLIPTA · AUSTEDO · Aimovig · AirDuo Digihaler · Amitiza · Austedo XR · BEVESPI AEROSPHERE · BREO · BREZTRI · BYDUREON · CHANTIX · Cologuard Collection Kit · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · GVOKE HYPOPEN · HETLIOZ · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Livalo · MOUNJARO · MYRBETRIQ · NEXLETOL · NURTEC ODT · NUZYRA · Otezla · Ozempic · PENTACEL · Prolia · QELBREE · QULIPTA · RYBELSUS · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Saxenda · Sivextro · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · UBRELVY · VERQUVO · VRAYLAR · VYVANSE · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · Xenleta · Xultophy 100/3.6 · ZEMBRACE SYMTOUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for dermatology in MI.

Looking for a dermatology specialist in Jenison?
Compare dermatologists in the Jenison area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
25
Per 100K population
8.4
County median income
$87,144
Nearest hospital
UNIVERSITY OF MICHIGAN HEALTH - WEST
6.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2023
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lugthart is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 3% of MI peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lugthart experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lugthart performed 17 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lugthart receive payments from pharmaceutical companies?
Yes. Dr. Lugthart received a total of $9,645 from 37 companies across 433 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lugthart's costs compare to other dermatologists in Jenison?
Dr. Lugthart's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Lugthart) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →